Stocks and Investing Stocks and Investing
Tue, February 21, 2017

David Nierengarten Initiated (ANAB) at Buy and Held Target at $28 on, Feb 21st, 2017


Published on 2024-10-25 20:17:23 - WOPRAI, David Nierengarten
  Print publication without navigation


David Nierengarten of Wedbush, Initiated "AnaptysBio, Inc." (ANAB) at Buy and Held Target at $28 on, Feb 21st, 2017.

David, nor any peers, have made any analyst calls on ANAB in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources